Cargando…
Challenges in transfusion and the role of Thalidomide in E‐β‐Thalassemia—A case report
Hemoglobin E‐β‐thalassemia is a common β‐thalassemia that has a variable presentation from mild to severe life‐threatening anemia. We describe such a case, who presented with severe anemia and multiple allo‐antibodies. Our case illustrates the role of thalidomide in transfusion‐sparing therapies in...
Autores principales: | Javed, Rizwan, Radhakrishnan, Vivek, Basu, Sabita, Chandy, Mammen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669370/ https://www.ncbi.nlm.nih.gov/pubmed/33235759 http://dx.doi.org/10.1002/ccr3.3141 |
Ejemplares similares
-
Incompatible crossmatch: First sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion
por: Basu, Debapriya, et al.
Publicado: (2019) -
Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study
por: Li, Xinyu, et al.
Publicado: (2021) -
Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial
por: Chen, Jiang-Ming, et al.
Publicado: (2021) -
Thalidomide for Patients with β-Thalassemia: A Multicenter Experience
por: Yang, Kun, et al.
Publicado: (2020) -
Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
por: Ansari, Saqib H., et al.
Publicado: (2022)